PDF Cover

Novalung System Market

The market for Novalung System was estimated at $1.6 billion in 2024; it is anticipated to increase to $2.5 billion by 2030, with projections indicating growth to around $3.6 billion by 2035.

Report ID:DS1801288
Author:Debadatta Patel - Senior Consultant
Published Date:
Datatree
Life Science
Medical Device
Novalung System
Share
Report Summary
Market Data
Methodology
Table of Contents

Global Novalung System Market Outlook

Revenue, 2024

$1.6B

Forecast, 2034

$3.4B

CAGR, 2025 - 2034

7.7%

The Novalung System industry revenue is expected to be around $1.7 billion in 2025 and expected to showcase growth with 7.7% CAGR between 2025 and 2034. The ongoing advancements in technology and the increasing number of elderly individuals globally are key drivers behind the continuous expansion of the Novalung System market. Additionally the enduring importance of the Novalung System stems from its impact on critical care treatments particularly for individuals facing acute respiratory or cardiopulmonary challenges. Its worth noting that this system is becoming increasingly vital in healthcare approaches given the rising prevalence of respiratory illnesses and the growing need, for less invasive treatment options.

The Novalung System is a technology that assists in gas exchange within the lungs from outside the body with minimal risk to organs and less need for ventilator support for patients. A crucial consideration amidst the worldwide shortage of ventilators today. The system is commonly used in scenarios such as preparing patients for organ transplants or helping them recover from respiratory issues, like acute respiratory distress syndrome.

Novalung System market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2024-2034
Novalung System Market Outlook

Market Key Insights

  • The Novalung System market is projected to grow from $1.6 billion in 2024 to $3.4 billion in 2034. This represents a CAGR of 7.7%, reflecting rising demand across Acute Respiratory Distress Syndrome (ARDS) Treatment and Chronic Obstructive Pulmonary Disease (COPD) Management.

  • Xenios AG, Getinge Group, and Medtronic plc are among the leading players in this market, shaping its competitive landscape.

  • U.S. and Germany are the top markets within the Novalung System market and are expected to observe the growth CAGR of 5.0% to 7.4% between 2024 and 2030.

  • Emerging markets including Brazil, India and South Korea are expected to observe highest growth with CAGR ranging between 8.9% to 10.6%.

  • Transition like Revolutionary Shift in Respiratory Care is expected to add $214 million to the Novalung System market growth by 2030.

  • The Novalung System market is set to add $1.8 billion between 2024 and 2034, with manufacturer targeting Cardiac Surgery Support & Intensive Care Units Application projected to gain a larger market share.

  • With Increased prevalence of respiratory diseases, and advancements in Lung Ventilation Systems, Novalung System market to expand 110% between 2024 and 2034.

novalung system market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032
Novalung System - Country Share Analysis

Opportunities in the Novalung System

The Novalung System has also the opportunity to reach customers by team up with hospitals or other healthcare and technology companies, in the industry to improve accessibility and develop the system further to meet the needs of different patients through joint research efforts.

Growth Opportunities in North America and Asia-Pacific

In North America's medical landscape market wise lead for extracorporeal lung assist systems is held by the Novalung System due to the increasing cases of illnesses in line with the aging demographic and lifestyle factors influencing this trend positively. There is competition among major players who are investing heavily in research and development to enhance their technology solutions and maintain a strong foothold in the market. Mergers and acquisitions are being closely observed as they present avenues, for market growth and fresh service approaches. It is crucial for healthcare organizations to stay updated on the changing policies and intricacies of insurance coverage since they directly influence market trends and user access.
The Asia Pacific region offers undiscovered chances for the Novalung System to expand its market reach effectively driven by the growth in healthcare spending and improvements in healthcare facilities with a rise in patient awareness of advanced treatment options leading to a surge in market demand in this region For both local and global entities comprehending the varied market scenarios within different nations and customizing approaches to fit these distinct cultural and operational environments is crucial, for long term prosperity. Despite facing competition from local and global competitors it is important to develop creative and user friendly interfaces that can smoothly connect with the fast changing digital health systems, in the region and provide effective clinical results.

Market Dynamics and Supply Chain

01

Driver: Increased Prevalence of Respiratory Diseases

The Novalung System is also a cutting edge technology designed to address the increasing incidence of illnesses in our society today. With the rise in conditions like chronic obstructive pulmonary disease and lung fibrosis there is also a growing need for solutions like this system to meet the demand for effective treatment options. This system shows promising potential, for expansion as it delivers Extracorporeal Membrane Oxygenation therapy by bypassing the lungs and establishing an artificial gas exchange platform.
Advancements in technology have also led to the development of sophisticated lung ventilation systems such as the Novalung System that offer effective treatment options, for patients requiring lung support and contribute to market expansion. The Novalung System also represents a progress by providing less invasive and more patient centered solutions compared to traditional mechanical ventilation methods. This innovation holds importance in treating severe lung conditions that do also not only respond well to standard treatments.
02

Restraint: High Initial Investment and Maintenance Cost

One major issue faced by the Novalung System in the market is its upfront cost and ongoing operational expenses for hospitals and healthcare facilities to manage efficiently within their budget constraints. Despite its impact on patient well being and quality of life improvement aspects that the system offers the high financial barriers could hinder its widespread adoption and demand, in the market.
03

Opportunity: Technological Advancements and Adoption and Emerging Markets Potential

Being one of the devices in Extra Corporeal Membrane Oxygenation technology the Novalung System provides cutting edge solutions for handling both acute and chronic lung conditions. The continuous evolution of respiratory care devices in the market and the growing acceptance of such technologies are expected to drive up the demand for the Novalung System, in the future Possible future upgrades could involve incorporating AI to tailor operations to suit each patients unique requirements.
The Novalung System stands to benefit from the growing concern about illnesses and the surge in healthcare investments in developing regions like Asia, Latin America and Africa. The ongoing expansion of healthcare facilities and the growing knowledge among patients about medical options could lead to a higher adoption of the Novalung System, in these areas.
04

Challenge: Limited Skilled Professionals

The deployment of advanced medical systems such as the Novalung System requires a plethora of skilled professionals. Unfortunately, there is a scarcity of trained professionals who can operate these sophisticated technologies effectively. This could lead to potential misuse or underutilization of the system, posing a serious challenge for the growth of the Novalung System market. These factors can hinder the understanding and recognition of the system, leading to decreased acceptance among healthcare providers.

Supply Chain Landscape

1

Raw Material Procurement

BASF SEDow Inc
2

Component Manufacturing

Medtronic PlcMaquet Holding BV & Co. KG
3

Assembly & Testing

Getinge ABFresenius Medical Care AG & Co
4

Distribution & End-Use Industry

HospitalsAmbulatory Surgical Centers
Novalung System - Supply Chain

Use Cases of Novalung System in Acute Respiratory Distress Syndrome (ARDS) Treatment & Chronic Obstructive Pulmonary Disease (COPD) Management

Acute Respiratory Distress Syndrome (ARDS) Treatment : The Novalung System is extensively used in the management of Acute Respiratory Distress Syndrome. This condition often requires advanced respiratory support, which this system aptly provides. It aids in carbon dioxide removal and oxygenation, promoting patient recovery. Propelled by clinical efficacy and reliability in emergency situations, frontline healthcare providers frequently turn to this system for ARDS treatment. Leading the market in this application are companies that prioritize the incorporation of cutting-edge technology, ensuring optimal patient outcomes.
Chronic Obstructive Pulmonary Disease (COPD) Management : In managing Chronic Obstructive Pulmonary Disease , the Novalung System exhibits significant application. Its ability to provide continuous, long-term respiratory support makes it a go-to for professionals seeking comprehensive patient care systems. It, especially the ventilation-assist devices, supports the natural lung function, facilitating the breathing process and optimizing oxygen delivery in COPD patients. Top players in the market, recognizing this, have adopted the system, differentiating themselves through superior patient care and treatment outcomes.

Recent Developments

As an industry pioneer in the field of extracorporeal technologies, Novalung System introduced significant developments that display promising prospective growth in the healthcare sector. Observing crucial market trends, it is noted that There is a surge in demand for advanced therapeutic solutions for acute respiratory and cardiopulmonary failure.

December 2024 : Pfizer, a key player in the Novalung System industry, announced the launch of an upgraded version of the Novalung System with enhanced patient-interface features for improved user experience
November 2024 : Novalung system received regulatory approval for sale in Japan, marking a significant expansion of its global footprint
September 2024 : Medtronic collaborated with Novalung to integrate AI algorithms into the Novalung System, aimed at boosting efficiency and accuracy in respiratory therapy.

Impact of Industry Transitions on the Novalung System Market

As a core segment of the Medical Device industry, the Novalung System market develops in line with broader industry shifts. Over recent years, transitions such as Revolutionary Shift in Respiratory Care and Emphasis on Technological Advancements have redefined priorities across the Medical Device sector, influencing how the Novalung System market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Revolutionary Shift in Respiratory Care

The introduction of the Novalung System represents a groundbreaking change in the field of care and medical technology innovation worldwide. The Novalung device functions as a membrane oxygenation system that facilitates the exchange of oxygen and elimination of carbon dioxide from a patients bloodstream to support lung function recovery and healing processes. This advancement is influencing sectors like medical equipment manufacturing and healthcare services on a global scale. The life saving capabilities of this technology are hospitals to increase their investments, in ECMO solutions resultantly propelling market expansion within these industries.
02

Emphasis on Technological Advancements

The industry is experiencing a transition towards more sophisticated ECMO systems like the Novalung System. This movement emphasizes increased efficiency, reduced complications, and enhanced patient comfort, thereby reshaping the standards of respiratory care technology. As a result, we are witnessing a dynamic change in the medical device manufacturing industry, with providers focusing on designing advanced respiratory care systems that incorporate these trends and meet the growing demand for technologically superior ECMO systems.